1.The lot size in Heranba IPO has been fixed at 23. At the upper price band of ₹627, one lot will cost ₹14,421 and retail investors can apply a maximum of 13 lots.
2) According to brokerages, the share allocation in Heranba IPO is likely to be finalised on March 2nd and listing may happen on March 5th.
3) Emkay Global Financial Services Ltd and Batlivala and Karani Securities India are the book running lead managers to the IPO.
4) Bigshare Services Pvt Ltd is the registrar of the IPO and will manage share allocation and refund.
5) Heranba is offering up to 99.8 lakh shares in the IPO, with 90.2 lakh shares under offer for sale and the rest through fresh issue of shares. The funds raised through fresh issue of shares will be utilised to finance the company’s working capital requirements and general corporate purposes.
6) Post issue, the shareholding of promoters will fall to 74.2%, from 98.8% earlier.
7) Today pyrethroids find usage in significant applications across pest protection, environmental health and crop care as well as animal health.
8) In FY20, the company had recorded a turnover of ₹951 crore as compared to ₹745 crore in FY18 while profit jumped to ₹97 crore from ₹50 crore.
9) According to the IPO prospectus, in 2019, Heranba Industries Limited dominated the India pyrethroids market, accounting for a share of 19.5% of the total Indian pyrethroids production values.